A study presented at the 2016 American Society of Clinical Oncology Annual Meeting in Chicago found an antibody-based experimental therapy is lengthening the life-span of patients suffering from ...

Editorial: Treatments continue to improve. The challenge now facing ministers is hugely unequal outcomes ...

Enhertu significantly improves overall survival in HER2-positive metastatic gastric cancer compared to ramucirumab and paclitaxel. DESTINY-Gastric04 is the first phase 3 trial showing Enhertu's ...

Huge improvements in prevention, diagnosis and treatment have driven the fall, Cancer Research UK says ...

Find out more about how AI has matched the diagnostic accuracy of expert endoscopists in detecting early gastric cancer.

Data on disease stage at presentation and treatment outcomes were obtained from the King Hussein Cancer Center registry. Patients were staged according to the US SEER staging system, which classifies ...

PolyPEPI1018 Cancer Vaccine and TAS-102 for Patients With Advanced, Chemo-Refractory, Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib Nonrandomized Study Using SEER 22 data, we analyzed ...

Of all early-onset cancers in the U.S., gastrointestinal cancers are increasing most rapidly, according to a review published July 17 in JAMA. Defined as occurring in patients under the age of 50, ...